Intrathecal baclofen. Literature review of the results and complications;Baclofène intrathécal. Analyse de la littérature des résultats et des complications

Neurochirurgie

Volumn 49, Issue 2-3 II, 2003, Pages 276-288

  Emery, E ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Baclofen; Complication; Functional gain; Intrathecal; Quality of life; Results; Spasticity

Indexed keywords

BACLOFEN; PLACEBO; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CENTRAL MUSCLE RELAXANT;

BRAIN INJURY; CATHETERIZATION; CEREBRAL PALSY; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; DISEASE SEVERITY; DRUG EFFICACY; EPILEPSY; FOLLOW UP; HUMAN; HYPOTENSION; MEDICAL LITERATURE; MENINGITIS; MUSCLE SPASM; MYALGIA; PATIENT MOBILITY; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SKIN NECROSIS; SKIN TOXICITY; SPASTICITY; SPINAL CORD DISEASE; TREATMENT OUTCOME; WOUND; CHILD; INTRASPINAL DRUG ADMINISTRATION;

BACLOFEN; CHILD; CLINICAL TRIALS; GABA AGONISTS; HUMANS; INJECTIONS, SPINAL; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY;

EID: 0037901796     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. ABEL NA, SMITH RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil 1994; 75: 54-58.
2. ALBRIGHT AL, CERVI A, SINGLETARY J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991; 265: 1418-1422.
3. ALBRIGHT AL, BARRON WB, FASICK MP. Continuous intra-thecal baclofen infusion for spasticity of cerebral origin. JAMA 1993; 270: 2475-2477.
4. ALBRIGHT AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996; 11 (suppl 1): S29-S35.
5. AKMAN MN, LOUBSER PG, DONOVAN WH, O'NEILL ME, ROSSI CD. Intrathecal balcofen: does tolerance occur? Paraplegia 1993; 31: 516-520.
6. ARMSTRONG RW, STEINBOK P, COCHRANE DD, KUBE SD, FIFE SE, FARRELL K. Intrathecal administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997; 87: 409-414.
7. AZOUVI P, MANE M, THIEBAUT JB, DENYS P, REMYNERIS O, BUSSEL B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996; 77: 35-39.
8. BARNES MP. Spasticity: a rehabilitation challenge in the elderly. Gerontology 2001; 47: 295-299.
9. BECKER R, ALBERTI O, BAUER BL. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 1997; 244: 160-166.
10. BENNETT MI, TAI YM, SYMONDS JM. Staphylococcal meningitis following Synchromed intrathecal pump implant: a case report. Pain 1994; 56: 243-244.
11. BROSETA J, GARCIA-MARCH G, SANCHEZ-LEDESMA MJ, ANAVA J, SILVA I. Chronic intrathecal baclofen administration in severe spasticity. Stereotact Funct Neurosurg 1990; 54-55: 147-153.
12. BURNS AS, MEYTHALER JM. Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord 2001; 39: 413-419.
13. BUTLER C, CAMPBELL S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel. Dev Med Child Neurol. 2000; 42: 634-645.
14. CAMPBELL SK, ALMEIDA GL, PENN RD, CORCOS DM. The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 1995; 75: 352-362.
15. COFFEY JR, CAHILL D, STEERS W, PARK TS, ORDIA J, MEYTHALER J, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226-232.
16. CONCALVESJ, GARCIA-MARCH G, SANCHEZ-LEDESMA MJ. Management of intractable spasticity of supraspinal origin by chronic cervical intra-thecal infusion of baclofen. Stereotact Funct Neurosurg 1994; 62: 108-112.
17. DARIO A, SCAMONI C, BONO G, GHEZZI A, ZAFFARONI M. Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion. Funct Neurol 2001; 16: 311-315.
18. DARIO A, DI STEFANO MG, GROSSI A, CASAGRANDE F, BONO G. Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand 2002; 105: 83-87.
19. DELHAAS EM, BROUWERS JR. Intrathecal baclofen overdose: report of 7 events in 5 patients and review of the literature. Int J Clin Pharmacol Ther Toxicol 1991; 29: 274-280.
20. DENYS P, MANE M, AZOUVI P, CHARTIER-KASTLER E, THIEBAULT JB, BUSSEL B. Side-effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil 1998; 79: 494-496.
21. FAKHOURY T, ABOU-KHALIL B, BLUMENKOPF B. EEG changes in intrathecal baclofen overdose: a case report and review of the literature. Electroencephalogr Clin Neurophysiol 1998; 107: 339-42.
22. GALLOWAY A, FALOPE FZ. Pseudomonas aeruginosa infection in an intrathecal baclofen pump: successful treatment with adjunct intra-reservoir gentamicin. Spinal Cord 2000; 38: 126-128.
23. GERSZTERN PC, ALBRIGHT AL, BARRY MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 1997; 27: 40-45.
24. GERSZTERN PC, ALBRIGHT AL, JOHNSON GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 1998; 88: 1009-1013.
25. GILMARTIN R, BRUCE D, STORRS BB, ABBOTT R, KRACH L, WARD J, et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 2000; 15: 71-77.
26. GORMLEY Jr ME, KRACH LE, PICCINI L. Spasticity management in the child with spastic quadriplegia. Eur J Neurol 2001, 8 (suppl 5): 127-135.
27. GREEN LB, NELSON VS. Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil 1999; 80: 1600-1604.
28. HEINEMANN AW, LINACRE JM, WRIGHT BD, HAMILTON BB, GRANGER C. Relationships between impairement and physical dosability as measured by the functional independence measure. Arch Phys Med Rehabil 1993; 74: 566-573.
29. HUCH K, KUNZ U, KLUGER P, PUHL W. Epidural blood patch under fluoroscopic control: non-surgical treatment of lumbar cerebrospinal fluid fistula following implantation of an intrathecal pump system. Spinal Cord 1999; 37: 648-652.
30. HURAIBI HA, PHILLIPS J, ROSE RJ, PALLATRONI H, WESTBROOK H. Intrathecal baclofen pump implantation complicated by epidural lipomatosis. Anesth Analg 2000; 91: 429-431.
31. IVANHOE CB, TILTON AH, FRANCISCO GE. Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehabil Clin N Am 2001; 12: 923-938.
32. KOFLER M, SALTUARI L SCHMUTZHARD E, BERCK K, BAUMGARTNER H, RUSSEGGER L, et al. Electrophysiological findings in a case of severe intrathecal baclofen overdose. Electroencephalogr Clin Neurophysiol 1992; 83: 83-86.
33. KOFLER M, KRONENBERG MF, RIFICI C, SALTUARI L, BAUER G. Epileptic seizures associated with intrathecal baclofen application. Neurology 1994; 44: 25-7.
34. LAZORTHES Y, SLLERIN-CAUTE B, VERDIE JC, BASTIDE R, CARILLO JP. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990; 72: 393-402.
35. LAZORTHESY, SALLERIN B, VERDIEJC, CASAUX, F, CARAOUÉ F, Sol JC. Traitement de la spasticité par administration intrathécale chronique de baclofène. Neurochirurgie 1998; 44: 201-208.
36. Mc LEAN BN. Intrathecal baclofen in severe spasticity. Br J Hosp Med 1993; 49: 262-267.
37. LEVIN AB, SPERLING KB. Complications associated with infusion pumps implanted for spasticity. Stereotact Funct Neurosurg 1995; 65: 147-151.
38. LOUBSER PG, NARAVAN RK, SANDIN KJ, DONOVAN WH, RUSSEL KD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity cord injury. Paraplegia 1991; 29: 48-64.
39. MARQUARDT G, SEIFERT V. Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr 2002; 72: 275-276.
40. MARQUARDT G, LORENZ R. Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis. J Neurol 1999; 246: 619-620.
41. MERTENS P, PARISE M, GARCIA-LARREA L, BENNETON C, MILLET MF, SINDOU M. Long-term clinical, electrophysiological and urodynamic effects of chronic intrathecal baclofen infusion for treatment of spinal spasticity. Acta Neurochir Suppl 1995; 64: 17-25.
42. MEYTHALER JM, STEERS WD, TUAL SM, CROSS LL, HAWORTH CS. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 1992; 71: 321-327.
43. MEYTHALER JM, De VIVO MJ, HADLEY MN. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 1996; 77: 461-466.
44. MEYTHALER JM, MCCARY A, HADLEY MN. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury a preliminary report. J Neurosurg 1997; 87: 415-419.
45. MEYTHALER JM, GUIN-RENFROE S, HADLEY MN. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil 1999; 78: 247-254.
46. MEYTHALER JM, GUIN-RENFROE S, GRABB P, HADLEY MN. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil 1999; 80: 13-19.
47. MEVTHALER JM, GUIN-RENFROE S, BRUNNER RC, HADLEY MN. Intrathecal baclofen for spastic hypertonia from strocke. Stroke 2001; 32: 2099-2109.
48. MEYTHALER JM, GUIN-RENFROE S, LAW C, GRABB P, HADLEY MN. Continuouslly infused intrathecally baclofen over 12 months for spastic hypertonia in adlolescent and adults with cerebral palsy. Arch Phys Med Rehabit 2001; 82: 155-161.
49. MIDDEL B, KUIPERS-UPMEIJER H, BOUMA J, STAAL M, OENEMA D, POSTMA T, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatr 1997; 63: 204-209.
50. MULLER-SCHWEFE G, PENN RD. Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases. J Neurosurg 1989; 71: 273-275.
51. MURPHY N, IRWIN MCN, HOFF C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil 2002; 83: 1721-1725.
52. NANCE P, SCHRYVERS O, SCHIMDT B, DUBO H, LOVERIDGE B, FEWER D. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995; 22: 22-29.
53. NIELSEN JF, HANSEN HJ, SUNDE N, CHRISTENSEN JJ. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen Clin Neurol Neurosurg 2002; 104: 142-145.
54. OCHS GA, TONN JC. Functional outcome and clinical significance of long-term intrathecal baclofen therapy for severe spasticity. J Neurol Rehabil 1996; 10: 159-166.
55. ORDIA JI, FISHER E, ADAMSKI E, SPATZ EL. Chronic ontrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 199; 85: 452-457.
56. PARKE B, PENN RD, SAVOY SM. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 1989; 70: 30-32.
57. PENN RD, KROIN JS. Intrathecal baclofen alleviates spinal cord spasticity (letter). Lancet 1984; 1: 1078.
58. PENN RD, KROIN JS. Continuous intrathecal baclofen for severe spasticity. Lancet 1985; 2: 125-127.
59. PENN RD, KROIN JS. Long-term intra thecal baclofen infusion for treatment of spsasticity. J Neurosurg 1987; 66: 181-5.
60. PENN RD, SAVOY S, CORCOS D, LATASH M, GOTTLISH G, PARKE B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989; 320: 1517-1521.
61. PENN RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992; 77: 236-240.
62. PIROTTE B, HEILPORN A, JOFFROY A, ZEGERS de BEYL D, WESEL P, BROTCHI J, et al. Chronic intrathecal baclofen in severely disabling spasticity: selection, clinical assessment and long-term benefit. Acta Neurol Belg 1995; 95: 216-225.
63. RAWICKI B. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients. J Neurosurg 1999; 91: 733-736.
64. REEVES RK, STOLP-SMITH KA, CHRISTOPHERSON MW. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch Phys Med Rehabil 1998; 79: 353-356.
65. RIFICI C, KOFLER M, KRONENBERG M. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Funct Neurol 1994; 9: 29-34.
66. SAHUQUILLO J, MUXI T, NOGUER M, JODAR R, CLOSA C, RUBIO E, et al. Intraspinal baclofen in the treatment of severe spasticity and spasms. Acta Neurochir (Wien) 1991; 110: 166-173.
67. SAMPSON FC, HAYWARD A, EVANS G, MORTON R, COLLETT B. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J. Neurosurg 2002; 96: 1052-1057.
68. SALTUARI L, KRONENBERG M, MAROSI MJ, KOFLER M, Russegger L, Rifici C, et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol (Napoli) 1992; 14: 187-194.
69. SAMPSON FC, HAYWARD A, EVANS G, MORTON R, COLLETT B. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 2002; 96: 1052-1057.
70. SCHEINBERG A, O'FLAHERTY S, CHASELING R, Dexter M. Continuous intrathecal baclofen infusion for children with cerebral palsy: a pilot study. J Paediatr Child Health 2001; 37: 283-288.
71. STEMPIEN L, TSAI T. Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 2000; 79: 536-541.
72. STEWART-WYNNE EG, SILBERT PI, BUFFERY S, PERLMAN D, TAN E. Intrathecal baclofen for severe spasticity: five years experience. Clin Exp Neurol 1991; 28: 244-255.
73. TEDDY P, JACOBSON L, TERMAN G. Complications of intrathecal baclofen delivery. Br J Neurosurg 1992; 6: 115-118.
74. VAN SCHAEYBROECK P, NUTTIN B, LAGAE L, SCHRIJVERS E, BORGHGRAEF C, FEVS P. Intrathecal baclofen for intrathecal cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 2000; 46: 603-609.
75. ZED PJ, STIVER HG, DEVONSHIRE V, JEWESSON PJ, MARRA F. Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pumpassociated meningitis. Case report. J Neurosurg 2000; 92: 347-349.
76. ZIERSKI J, MULLER H, DRALLE D, WURDINGER T. Implanted pump systems for treatment of spasticity. Acta Neurochir Suppl 1988; 43: 94-99.